Genentech/NNP Inc./NNP said/VBD 0/-NONE- the/DT West/NNP German/NNP distributor/NN of/IN its/PRP$ heart/NN drug/NN TPA/NNP reached/VBD a/DT joint/NN marketing/NN agreement/NN with/IN a/DT subsidiary/NN of/IN Hoechst/NNP AG/NNP ,/, which/WDT *T*-1/-NONE- makes/VBZ the/DT rival/JJ anti-clotting/JJ agent/NN streptokinase/NNP ./.
The/DT biotechnology/NN concern/NN said/VBD 0/-NONE- the/DT agreement/NN between/IN its/PRP$ longtime/NN West/NNP German/NNP distributor/NN ,/, Boehringer-Ingleheim/NNP 's/POS Dr./NNP Karl/NNP Thomae/NNP G.m.b.H./NNP subsidiary/NN ,/, and/CC Hoechst/NNP 's/POS Behringwerke/NNP subsidiary/NN was/VBD an/DT attempt/NN */-NONE- to/TO expand/VB the/DT market/NN for/IN blood-clot/NN drugs/NNS in/IN general/NN ./.
A/DT Genentech/NNP spokeswoman/NN said/VBD 0/-NONE- the/DT agreement/NN calls/VBZ for/IN Hoechst/NNP to/TO promote/VB TPA/NNP for/IN heart/NN patients/NNS and/CC streptokinase/NNP for/IN other/JJ clot-reducing/JJ purposes/NNS ./.

